In the United States, an estimated 15.4 million people are treated for asthma each year. This places an enormous burden on both individual patients and the US economy.

The US Food and Drug Administration (FDA) has approved the first generic Advair Diskus to treat asthma and chronic obstructive pulmonary disease (COPD).

The US Food and Drug Administration (FDA) has approved the only asthma inhaler available over the counter (OTC) in the United States.

The US Food and Drug Administration (FDA) has approved a new device to treat breathing trouble tied to severe emphysema.

COPD, a common lung disease, used to be considered a disease that primarily occurs in men. However, in recent years, more women have been diagnosed with COPD.